Article(id=1327672443075932896, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672325740278619, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2022.09.020, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1650038400000, receivedDateStr=2022-04-16, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794471377390, onlineDateStr=2026-11-12, pubDate=1662739200000, pubDateStr=2022-09-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794471377390, onlineIssueDateStr=2026-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794471377390, creator=13701087609, updateTime=1794471377390, updator=13701087609, issue=Issue{id=1327672325740278619, tenantId=1146029695717560320, journalId=1319690259887390882, year='2022', volume='53', issue='9', pageStart='1227', pageEnd='1376', issueExtLink='null', onlineDate='null', pubDate='1662739200000', pubDateStr='2022-09-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794471349414, creator='13701087609', updateTime=1794472133529, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1327675615098024900, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672325740278619, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1327675615098024901, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672325740278619, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1360, endPage=1364, ext={EN=ArticleExt(id=1327672443260482273, articleId=1327672443075932896, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Survey on China's Improved New Drug Development and Clinical Advantages Considerations for Registration Requirements, columnId=1322624444787438528, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Pharmaceutical Management & Information, runingTitle=null, highlight=null, articleAbstract=null, authors=Hongwei CHANG, authorsList=Hongwei CHANG, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1327672443633775331, articleId=1327672443075932896, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=国内改良型新药研发现状和临床优势的注册考量, columnId=1322624444934239170, journalTitle=中国医药工业杂志, columnName=药学管理与信息, runingTitle=null, highlight=null, articleAbstract=

按照2016年颁布的药品注册分类办法,改良型新药属于2类新药。相较于创新药的创新性要求、仿制药的一致性要求,改良型新药更侧重药品的优效性,具体表现为提高有效性、改善安全性、提高依从性。目前,国内改良型新药仍处于起步阶段,但申报数量逐年递增。该文梳理并分析了自新的注册分类改革至今,国内改良型新药相关的政策法规和受理获批情况,并结合工作实际,对改良型新药在临床优势方面的注册考量提供一些建议,以期为改良型新药研发和注册申报提供有价值的参考。

, authors=常洪委, authorsList=常洪委, authorCompany=null, correspAuthors=null, authorNote=

常洪委(1987—),男,工程师,从事药物研发和制药工艺研究。E-mail:

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=ykeo83XFOvqz4JgYyVGHdw==, magXml=1H8+EHmB2Ie0cCngeq/ocg==, pdfUrl=null, pdf=BzanZZn0CckMOnmBigb20g==, pdfFileSize=2055931, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=sm3Yb+xL44UcUP+B4drxAA==, mapNumber=null, fund=null)}, authors=[Author(id=1327672445517017832, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=chhwzhiyao@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672445588321002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, authorId=1327672445517017832, language=EN, stringName=Hongwei CHANG, firstName=Hongwei, middleName=null, lastName=CHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Taizhou Medical Hi-Tech Zone Public Service Platform, Taizhou 225300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672445651235563, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, authorId=1327672445517017832, language=CN, stringName=常洪委, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=泰州市医药高新技术产业园区公共平台服务中心,江苏 泰州 225300, bio={"content":"

常洪委(1987—),男,工程师,从事药物研发和制药工艺研究。E-mail:

"}, bioImg=null, bioContent=

常洪委(1987—),男,工程师,从事药物研发和制药工艺研究。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672445424743140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, xref=null, ext=[AuthorCompanyExt(id=1327672445428937445, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, companyId=1327672445424743140, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Taizhou Medical Hi-Tech Zone Public Service Platform, Taizhou 225300), AuthorCompanyExt(id=1327672445437326054, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, companyId=1327672445424743140, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=泰州市医药高新技术产业园区公共平台服务中心,江苏 泰州 225300)])])], keywords=[Keyword(id=1327672445751898860, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, language=CN, orderNo=1, keyword=改良型新药), Keyword(id=1327672445814813421, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, language=CN, orderNo=2, keyword=药品申报), Keyword(id=1327672445923865326, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, language=CN, orderNo=3, keyword=临床优势)], refs=[Reference(id=1327672446020334319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局.总局关于发布化学药品注册分类改革工作方案的公告(2016年第51号)[EB/OL].(2016-03-09)[2022-03-12].https://www.nmpa.gov.cn/yaopin/ypggtg/ypqtgg/20160309151801706.htm., articleTitle=null, refAbstract=null), Reference(id=1327672446074860272, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=BIO industry analysis.Clinical development success rates 2006-2015[EB/OL].(2019-07-31)[2022-04-25].https://www.bio.org/sites/default/files/legacy/bioorg/docs/Clinical Development., articleTitle=null, refAbstract=null), Reference(id=1327672446137774833, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局.国家药监局关于发布化学药品注册分类及申报资料要求的通告(2020年第44号)[EB/OL].(2020-06-30)[2022-03-12].https://www.nmpa.gov.cn/yaopin/ypggtg/ypqtgg/20200630180301525.html., articleTitle=null, refAbstract=null), Reference(id=1327672446221660914, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=钟慧娟,岑均达,王广基,等.新型抗精神类药物奥氮平及其制剂(欧兰宁)的研制和产业化[EB/OL].[2022-04-25].http://cnki.scstl.org/KCMS/detail/detail.aspx?filename=SNAD000001539518&dbcode=SNAD., articleTitle=null, refAbstract=null), Reference(id=1327672446288769779, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=孙菁,蒋新国,李瑞,等.一种包载难溶性抗肿瘤药物的聚合物胶束冻干制剂:中国,102218027B [P].2014-07-02., articleTitle=null, refAbstract=null), Reference(id=1327672446381044468, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=GAO Y, HUANG H, WANG X, et al.Safety and efficacy of mitoxantrone hydrochloride liposome in patients with relapsed or refractory peripheral T-cell lymphoma and extranodal NK/T-cell lymphoma: a prospective, single-arm, open-label, multi-center, phase Ⅱ clinical trial [J].Blood,2020, 136(Suppl 1): 36-37., articleTitle=null, refAbstract=null), Reference(id=1327672446443959029, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=CDE.国家药监局药审中心关于发布《化学药品改良型新药临床试验技术指导原则》的通告(2020年第54号)[EB/OL].(2020-12-30)[2022-03-12].https://www.cde.org.cn/main/news/viewInfoCommon/7be5bee1f6c5d63ed5571c5049715e8a., articleTitle=null, refAbstract=null), Reference(id=1327672446506873590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=CDE.关于发布化学仿制药参比制剂遴选与确定程序的公告(2019年第25号)[EB/OL].(2019-03-25)[2022-03-12].https://www.cde.org.cn/main/policy/view/058ddb35127bbd69e306855e4442f664., articleTitle=null, refAbstract=null), Reference(id=1327672446599148279, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=刘冬,韩鸿璨,安娜,等.我国化学仿制药参比制剂落选品种的特征分析[J].药物评价研究,2022,45(2):221-226., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1327672445424743140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, xref=null, ext=[AuthorCompanyExt(id=1327672445428937445, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, companyId=1327672445424743140, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Taizhou Medical Hi-Tech Zone Public Service Platform, Taizhou 225300), AuthorCompanyExt(id=1327672445437326054, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, companyId=1327672445424743140, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=泰州市医药高新技术产业园区公共平台服务中心,江苏 泰州 225300)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.09.020, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.09.020, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2022.09.020, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2022.09.020, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1662739200000, fullTextJson=null, articleText=null, reference=null)
收藏切换
国内改良型新药研发现状和临床优势的注册考量
常洪委
中国医药工业杂志 | 药学管理与信息 2022,53(9): 1360-1364
收起
收藏切换
中国医药工业杂志 |药学管理与信息 2022 , 53 (9) : 1360 -1364
国内改良型新药研发现状和临床优势的注册考量
全屏
[Author(id=1327672445517017832, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=chhwzhiyao@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672445588321002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, authorId=1327672445517017832, language=EN, stringName=Hongwei CHANG, firstName=Hongwei, middleName=null, lastName=CHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Taizhou Medical Hi-Tech Zone Public Service Platform, Taizhou 225300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672445651235563, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, authorId=1327672445517017832, language=CN, stringName=常洪委, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=泰州市医药高新技术产业园区公共平台服务中心,江苏 泰州 225300, bio={"content":"

常洪委(1987—),男,工程师,从事药物研发和制药工艺研究。E-mail:

"}, bioImg=null, bioContent=

常洪委(1987—),男,工程师,从事药物研发和制药工艺研究。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672445424743140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, xref=null, ext=[AuthorCompanyExt(id=1327672445428937445, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, companyId=1327672445424743140, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Taizhou Medical Hi-Tech Zone Public Service Platform, Taizhou 225300), AuthorCompanyExt(id=1327672445437326054, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672443075932896, companyId=1327672445424743140, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=泰州市医药高新技术产业园区公共平台服务中心,江苏 泰州 225300)])])]
常洪委
作者信息
  • 泰州市医药高新技术产业园区公共平台服务中心,江苏 泰州 225300
作者简介:

常洪委(1987—),男,工程师,从事药物研发和制药工艺研究。E-mail:

Survey on China's Improved New Drug Development and Clinical Advantages Considerations for Registration Requirements
Hongwei CHANG
Affiliations
  • Taizhou Medical Hi-Tech Zone Public Service Platform, Taizhou 225300
出版时间: 2022-09-10 doi: 10.16522/j.cnki.cjph.2022.09.020
文章导航
收藏切换

按照2016年颁布的药品注册分类办法,改良型新药属于2类新药。相较于创新药的创新性要求、仿制药的一致性要求,改良型新药更侧重药品的优效性,具体表现为提高有效性、改善安全性、提高依从性。目前,国内改良型新药仍处于起步阶段,但申报数量逐年递增。该文梳理并分析了自新的注册分类改革至今,国内改良型新药相关的政策法规和受理获批情况,并结合工作实际,对改良型新药在临床优势方面的注册考量提供一些建议,以期为改良型新药研发和注册申报提供有价值的参考。

改良型新药  /  药品申报  /  临床优势
常洪委. 国内改良型新药研发现状和临床优势的注册考量. 中国医药工业杂志, 2022 , 53 (9) : 1360 -1364 . DOI: 10.16522/j.cnki.cjph.2022.09.020
Hongwei CHANG. Survey on China's Improved New Drug Development and Clinical Advantages Considerations for Registration Requirements[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (9) : 1360 -1364 . DOI: 10.16522/j.cnki.cjph.2022.09.020

参考文献 引证文献
排序方式:
[1]
国家药品监督管理局.总局关于发布化学药品注册分类改革工作方案的公告(2016年第51号)[EB/OL].(2016-03-09)[2022-03-12].https://www.nmpa.gov.cn/yaopin/ypggtg/ypqtgg/20160309151801706.htm.
[2]
BIO industry analysis.Clinical development success rates 2006-2015[EB/OL].(2019-07-31)[2022-04-25].https://www.bio.org/sites/default/files/legacy/bioorg/docs/Clinical Development.
[3]
国家药品监督管理局.国家药监局关于发布化学药品注册分类及申报资料要求的通告(2020年第44号)[EB/OL].(2020-06-30)[2022-03-12].https://www.nmpa.gov.cn/yaopin/ypggtg/ypqtgg/20200630180301525.html.
[4]
钟慧娟,岑均达,王广基,等.新型抗精神类药物奥氮平及其制剂(欧兰宁)的研制和产业化[EB/OL].[2022-04-25].http://cnki.scstl.org/KCMS/detail/detail.aspx?filename=SNAD000001539518&dbcode=SNAD.
[5]
孙菁,蒋新国,李瑞,等.一种包载难溶性抗肿瘤药物的聚合物胶束冻干制剂:中国,102218027B [P].2014-07-02.
[6]
GAO Y, HUANG H, WANG X, et al.Safety and efficacy of mitoxantrone hydrochloride liposome in patients with relapsed or refractory peripheral T-cell lymphoma and extranodal NK/T-cell lymphoma: a prospective, single-arm, open-label, multi-center, phase Ⅱ clinical trial [J].Blood,2020, 136(Suppl 1): 36-37.
[7]
CDE.国家药监局药审中心关于发布《化学药品改良型新药临床试验技术指导原则》的通告(2020年第54号)[EB/OL].(2020-12-30)[2022-03-12].https://www.cde.org.cn/main/news/viewInfoCommon/7be5bee1f6c5d63ed5571c5049715e8a.
[8]
CDE.关于发布化学仿制药参比制剂遴选与确定程序的公告(2019年第25号)[EB/OL].(2019-03-25)[2022-03-12].https://www.cde.org.cn/main/policy/view/058ddb35127bbd69e306855e4442f664.
[9]
刘冬,韩鸿璨,安娜,等.我国化学仿制药参比制剂落选品种的特征分析[J].药物评价研究,2022,45(2):221-226.
2022年第53卷第9期
91
17
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2022.09.020
  • 接收时间:2022-04-16
  • 首发时间:2026-11-12
  • 出版时间:2022-09-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-04-16
基金
作者信息
    泰州市医药高新技术产业园区公共平台服务中心,江苏 泰州 225300
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.09.020
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏